These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38791922)

  • 1. Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma-Cohort Study.
    Park SH; Kang IC; Hong SS; Kim HY; Hwang HK; Kang CM
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791922
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Significance of Glucose to Lymphocyte Ratio (GLR) as a Prognostic Marker for Patients With Pancreatic Cancer.
    Zhong A; Cheng CS; Kai J; Lu R; Guo L
    Front Oncol; 2020; 10():520330. PubMed ID: 33117673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - a retrospective tumor marker prognostic study.
    Distler M; Pilarsky E; Kersting S; Gr├╝tzmann R
    Int J Surg; 2013; 11(10):1067-72. PubMed ID: 24161419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer.
    Zhang Y; Xu Y; Wang D; Kuang T; Wu W; Xu X; Jin D; Lou W
    Int J Clin Oncol; 2021 Jan; 26(1):135-144. PubMed ID: 32959232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Wang CF
    World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative gamma-glutamyltransferase to lymphocyte ratio predicts long-term outcomes in intrahepatic cholangiocarcinoma patients following hepatic resection.
    Wang JJ; Li H; Li JX; Xu L; Wu H; Zeng Y
    World J Gastroenterol; 2020 Apr; 26(13):1501-1512. PubMed ID: 32308350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of glucose to lymphocyte ratio for patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A multi-institutional, propensity score matching cohort study.
    Ni J; Li Z; Song W; Zhang H; Wang Y; Zhang Y; Zhang H; Yang G; Xie J; Wang K; Peng B; Mao W
    Front Surg; 2022; 9():911411. PubMed ID: 36248373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of preoperative PNI and CA19-9 for pancreatic ductal adenocarcinoma: A multi-institutional retrospective study.
    Itoh S; Tsujita E; Fukuzawa K; Sugimachi K; Iguchi T; Ninomiya M; Maeda T; Kajiyama K; Adachi E; Uchiyama H; Utsunomiya T; Ikeda Y; Maekawa S; Toshima T; Harada N; Yoshizumi T; Mori M
    Pancreatology; 2021 Oct; 21(7):1356-1363. PubMed ID: 34426076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated serum CA19-9 level is a promising predictor for poor prognosis in patients with resectable pancreatic ductal adenocarcinoma: a pilot study.
    Dong Q; Yang XH; Zhang Y; Jing W; Zheng LQ; Liu YP; Qu XJ
    World J Surg Oncol; 2014 Jun; 12():171. PubMed ID: 24890327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
    Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
    JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose to Lymphocyte Ratio as a Prognostic Marker in Patients With Resected pT2 Gallbladder Cancer.
    Navarro J; Kang I; Hwang HK; Yoon DS; Lee WJ; Kang CM
    J Surg Res; 2019 Aug; 240():17-29. PubMed ID: 30909062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated preoperative plasma D-dimer level was an independent prognostic factor for patients with PDAC after curative resection: a retrospective analysis.
    Zhifei L; Yuexiang L; Shaofei C; Shuo L; Hongwei W; Chuntao G
    Jpn J Clin Oncol; 2023 Nov; 53(11):1058-1067. PubMed ID: 37539583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas.
    Napoli N; Kauffmann EF; Ginesini M; Lami L; Lombardo C; Vistoli F; Campani D; Boggi U
    Updates Surg; 2023 Sep; 75(6):1481-1496. PubMed ID: 37535191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Long-Term Outcome for Patients with Pancreatic Ductal Adenocarcinoma.
    Kubota K; Shimizu A; Notake T; Masuo H; Hosoda K; Yasukawa K; Hayashi H; Umemura K; Kamachi A; Goto T; Tomida H; Yamazaki S; Soejima Y
    Ann Surg Oncol; 2022 Feb; 29(2):1437-1448. PubMed ID: 34664139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative Alkaline Phosphatase-to-Cholesterol Ratio as a Predictor of Overall Survival in Pancreatic Ductal Adenocarcinoma Patients Undergoing Radical Pancreaticoduodenectomy.
    Qiu G; Zhang L; Gu Z; Ren H; Du Y; Li Z; Wang C
    Med Sci Monit; 2021 Oct; 27():e931868. PubMed ID: 34599137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma.
    Abe T; Amano H; Kobayashi T; Hanada K; Nakahara M; Ohdan H; Noriyuki T
    Eur J Surg Oncol; 2018 Oct; 44(10):1573-1579. PubMed ID: 29807728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study.
    Miyata T; Hayashi H; Yamashita YI; Matsumura K; Nakao Y; Itoyama R; Yamao T; Tsukamoto M; Okabe H; Imai K; Chikamoto A; Ishiko T; Baba H
    Ann Surg Oncol; 2021 Mar; 28(3):1572-1580. PubMed ID: 32804325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma.
    Shimagaki T; Sugimachi K; Mano Y; Onishi E; Iguchi T; Nakashima Y; Sugiyama M; Yamamoto M; Morita M; Toh Y
    Ann Gastroenterol Surg; 2023 Nov; 7(6):977-986. PubMed ID: 37927935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.